Page 99 - 《中国药房》2026年2期
P. 99

[ 6 ]  EGGER  J,GSAXNER  C,PEPE A,et  al.  Medical  deep   [19]  程颖,柳菁菁. 《中国肿瘤药物治疗相关恶心呕吐防治专
              learning:a  systematic  meta-review[J].  Comput  Methods   家共识(2022 年版)》解读[J]. 临床内科杂志,2023,40
              Programs Biomed,2022,221:106874.                   (5):351-353.
          [ 7 ]  QAMAR  T,BAWANY  N  Z.  Understanding  the  black-  [20]  NAVARI  R  M,AAPRO  M.  Antiemetic  prophylaxis  for
              box:towards interpretable and reliable deep learning models  chemotherapy-induced  nausea  and  vomiting[J].  N  Engl  J
              [J]. PeerJ Comput Sci,2023,9:e1629.                 Med,2016,374(14):1356-1367.
          [ 8 ]  ROBSON B,COOPER R. Glass box and black box ma‐  [21]  PETCH J,DI S,NELSON W. Opening the black box:the
              chine  learning  approaches  to  exploit  compositional  des-  promise  and  limitations  of  explainable  machine  learning
              criptors of molecules in drug discovery and aid the medicinal   in cardiology[J]. Can J Cardiol,2022,38(2):204-213.
              chemist[J]. ChemMedChem,2024,4:e202400169.     [22]  BLACKMAN J,VEERAPEN R. On the practical,ethical,
          [ 9 ]  MUL  FEDELE  M  L,DEL  PILAR  LÓPEZ  GABEIRAS    and  legal  necessity  of  clinical  artificial  intelligence  ex‐
              M,SIMONELLI G,et al. Multivariate analysis of the im‐  plainability:an  examination  of  key  arguments[J].  BMC
              pact  of  sleep  and  working  hours  on  medical  errors:a   Med Inform Decis Mak,2025,25(1):111.
              MICE  approach[J].  BMC  Public  Health,2023,23(1):  [23]  SAKAI C,SHIMOKAWA M,IIHARA H,et al. Low-dose
              2317.                                               olanzapine  plus  granisetron  and  dexamethasone  for
          [10]  ALKHAWALDEH I M,ALBALKHI I,NASWHAN A J.           carboplatin-induced nausea and vomiting in patients with
              Challenges and limitations of synthetic minority oversam‐  thoracic malignancies:a prospective multicenter phase Ⅱ
              pling  techniques  in  machine  learning[J]. World  J  Metho-  trial[J]. Oncologist,2021,26(6):e1066-e1072.
              dol,2023,13(5):373-378.                        [24]  SARMA I D,BURAGOHAIN S,LAHON J,et al. Aprepi‐
          [11]  ZHOU Z H,FENG J. Deep forest[J]. Natl Sci Rev,2019,6  tant versus olanzapine in patients of breast cancer on adria‐
              (1):74-86.                                          mycin  and  cyclophosphamide  regimen:role  in  effective‐
          [12]  LUNDBERG S M,ERION G,CHEN H,et al. From local     ness  of  prevention  of  nausea  and  vomiting[J]. Acta  Med
              explanations to global understanding with explainable AI   Litu,2025,32(1):118-119.
              for trees[J]. Nat Mach Intell,2020,2(1):56-67.  [25]  BOURDEANU  L,FRANKEL  P,YU  W,et  al.
          [13]  DRANITSARIS G,MOLASSIOTIS A,CLEMONS M,et          Chemotherapy-induced  nausea  and  vomiting  in  Asian
              al. The development of a prediction tool to identify cancer   women  with  breast  cancer  receiving  anthracycline-based
              patients at high risk for chemotherapy-induced nausea and   adjuvant chemotherapy[J]. J Support Oncol,2012,10(4):
              vomiting[J]. Ann Oncol,2017,28(6):1260-1267.        149-154.
          [14]  HU Z H,LIANG W H,YANG Y P,et al. Personalized es‐  [26]  KAISER R,SEZER O,PAPIES A,et al. Patient-tailored
              timate of chemotherapy-induced nausea and vomiting:de‐  antiemetic treatment with 5-hydroxytryptamine type 3 re‐
              velopment and external validation of a nomogram in can‐  ceptor  antagonists  according  to  cytochrome  P-450  2D6
              cer patients receiving highly/moderately emetogenic che‐  genotypes[J]. J Clin Oncol,2002,20(12):2805-2811.
              motherapy[J]. Medicine,2016,95(2):e2476.       [27]  PERWITASARI D A,GELDERBLOM H,ATTHOBARI
          [15]  AGUIAR ZDOVC J,VAUPOTIČ M,MAROLT G,et al.         J,et al. Anti-emetic drugs in oncology:pharmacology and
              Population  pharmacokinetics  of  cisplatin  in  small  cell   individualization  by  pharmacogenetics[J].  Int  J  Clin
              lung  cancer  patients  guided  with  informative  priors[J].   Pharm,2011,33(1):33-43.
              Cancer Chemother Pharmacol,2022,90(4):301-313.  [28]  ELIASEN A,DALHOFF K,MATHIASEN R,et al. Phar‐
          [16]  BÉGUIN J,MAHFOUDHI S,UZEL M,et al. Population     macogenetics  of  antiemetics  for  chemotherapy-induced
              pharmacokinetics  modelling  for  clinical  dose  adjustment   nausea  and  vomiting:a  systematic  review  and  meta-
              of carboplatin in dogs[J]. BMC Vet Res,2024,20(1):575.  analysis[J]. Crit Rev Oncol Hematol,2020,149:102939.
          [17]  IMAMURA Y,KIYOTA N,TAHARA M,et al. Effect of   [29]  MEHROTRA S,SHARMA M R,GRAY E,et al. Kinetic-
              acute  kidney  injury  and  overall  survival  in  patients  with   pharmacodynamic  model  of  chemotherapy-induced  pe‐
              postoperative head and neck cancer who received chemo‐  ripheral neuropathy in patients with metastatic breast can‐
              radiotherapy  with  cisplatin:a  supplementary  analysis  of   cer treated with paclitaxel,nab-paclitaxel,or ixabepilone:
              the phase Ⅱ/Ⅲ trial of JCOG1008[J]. Cancer Med,2024,  CALGB 40502 (alliance)[J]. AAPS J,2017,19(5):1411-
              13(18):e70235.                                      1423.
          [18]  中国药学会医院药学专业委员会. 化疗所致恶心呕吐的                                   (收稿日期:2025-07-22  修回日期:2025-12-13)
              药物防治指南[J]. 中国医院药学杂志,2022,42(5):                                                     (编辑:舒安琴)
              457-473.








          中国药房  2026年第37卷第2期                                                 China Pharmacy  2026 Vol. 37  No. 2    · 225 ·
   94   95   96   97   98   99   100   101   102   103   104